High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study
Top Cited Papers
- 1 December 2001
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 358 (9298), 2026-2033
- https://doi.org/10.1016/s0140-6736(01)07098-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Coronary artery disease in patients at low risk — apolipoprotein AI as an independent risk factorAtherosclerosis, 2001
- Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease EventsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Treatment of DyslipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- LDL Size and Risk of Coronary Heart Disease in Elderly Men and WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary PreventionEuropean Heart Journal, 1998
- Apolipoprotein B and Coronary Artery Disease in WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)Circulation, 1998
- Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular StudyCirculation, 1996
- The Role of Lipoprotein A-I and Lipoprotein A-I/A-II in Predicting Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1995